Table 2.
The results of association analysis for CD16+ monocytes.
| Variables | CD16+ monocyte level | p value | |||
|---|---|---|---|---|---|
| 6.5~15.6 | >15.6, ≤18.6 | >18.6, ≤21.5 | >21.5, ≤29.2 | ||
| n | 34 | 34 | 34 | 33 | |
| n (%) | n (%) | n (%) | n (%) | ||
| Sex | |||||
| Female | 15 (44.12%) | 14 (41.18%) | 15 (44.12%) | 18(54.55%) | 0.374 |
| Male | 19 (55.88%) | 20 (58.82%) | 19 (55.88%) | 15(45.45%) | |
| DM | |||||
| No | 20 (58.82%) | 18 (52.94%) | 16 (47.06%) | 13(39.39%) | 0.083 |
| Yes | 14 (41.18%) | 16 (47.06%) | 18 (52.94%) | 20(60.61%) | |
| Hypertension | 0.806 | ||||
| No | 8 (23.53%) | 11 (32.35%) | 11 (32.35%) | 8(24.24%) | |
| Yes | 26 (76.47%) | 23 (67.65%) | 23 (67.65%) | 25(75.76%) | |
| Preexisting CAD or CeVD | |||||
| No | 22 (64.71%) | 20 (58.82%) | 13 (40.63%) | 7(21.21%) | <0.0001∗ |
| Yes | 12 (35.29%) | 14 (41.18%) | 19 (59.38%) | 26(78.79%) | |
| HD vintage (year) | |||||
| 0–3 | 7 (20.59%) | 4 (11.76%) | 6 (17.65%) | 3(9.09%) | 0.849 |
| >3, ≤5 | 8 (23.53%) | 10 (29.41%) | 8 (23.53%) | 11(33.33%) | |
| >5, ≤8 | 6 (17.65%) | 11 (32.35%) | 14 (41.18%) | 6(18.18%) | |
| >8 | 13 (38.24%) | 9 (26.47%) | 6 (17.65%) | 13(39.39%) | |
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| CD16+ monocytes, % | 12.77 ± 2.32 | 16.96 ± 0.87 | 20.28 ± 0.87 | 24.77 ± 2.07 | — |
| HD vintage, year | 7.99 ± 5.74 | 6.8 ± 3.81 | 6.29 ± 3.82 | 6.89 ± 3.59 | 0.753 |
| Age, year | 56.03 ± 12.03 | 59.91 ± 11.35 | 61.59 ± 13.15 | 63.45 ± 10.67 | 0.004∗ |
| BMI, kg/m2 | 23.1 ± 3.38 | 23.31 ± 3.64 | 23.1 ± 3.27 | 25.03 ± 3.88 | 0.238 |
| WBC, 103/mm3 | 7.08 ± 2.12 | 6.28 ± 1.43 | 6.53 ± 1.58 | 6.32 ± 1.35 | 0.245 |
| Monocyte, 103/μl | 5.71 ± 1.77 | 5.89 ± 1.58 | 6.27 ± 1.74 | 6.06 ± 1.47 | 0.192 |
| AbsoMono, cells/μl | 413.94 ± 214.01 | 366.77 ± 117.41 | 408.65 ± 149.62 | 380.39 ± 120.19 | 0.961 |
| HsCRP, mg/l | 2.57 ± 1.42 | 2.42 ± 1.46 | 2.49 ± 1.41 | 2.96 ± 1.34 | 0.367 |
| Hb, g/dl | 11.47 ± 1.59 | 11.39 ± 1.31 | 11.15 ± 1.57 | 10.97 ± 1.27 | 0.135 |
| PLT, 104/cm3 | 143.21 ± 90.39 | 124.96 ± 82.61 | 163.69 ± 88.49 | 153.32 ± 89.62 | 0.311 |
| FBS, mg/dl | 110.85 ± 42.25 | 111.86 ± 43.94 | 126.56 ± 59.31 | 114.76 ± 45.17 | 0.732 |
| HbA1c, % | 6.38 ± 1.72 | 5.96 ± 1.29 | 6.29 ± 1.33 | 6.59 ± 1.71 | 0.198 |
| Albumin, g/dl | 4.24 ± 0.22 | 4.43 ± 1.45 | 4.18 ± 0.32 | 4.1 ± 0.29 | 0.163 |
| Ferritin, μg/dl | 657.41 ± 256.8 | 594.68 ± 271.22 | 745.94 ± 326.2 | 717.58 ± 288.81 | 0.041∗ |
| TG, mg/dl | 144.56 ± 107.83 | 132.05 ± 73.32 | 154.29 ± 105.66 | 141.42 ± 83.4 | 0.782 |
| HDL, mg/dl | 47.18 ± 17.99 | 48.82 ± 17.11 | 48.03 ± 19.79 | 43.48 ± 14.52 | 0.877 |
| Cholesterol, mg/dl | 168.5 ± 37.08 | 165.7 ± 37.16 | 161.24 ± 37.81 | 164.12 ± 41.12 | 0.767 |
| rTG | 0.86 ± 0.6 | 0.82 ± 0.39 | 0.9 ± 0.52 | 0.88 ± 0.49 | 0.805 |
| rHDL | 0.29 ± 0.11 | 0.31 ± 0.12 | 0.3 ± 0.11 | 0.27 ± 0.09 | 0.757 |
| cHDL, mg/dl | 121.32 ± 36.73 | 116.58 ± 37.82 | 113.21 ± 34.76 | 120.64 ± 38.17 | 0.689 |
| BUN, mg/dl | 67.6 ± 14.69 | 67.32 ± 12.52 | 66.88 ± 12.84 | 65.98 ± 15.42 | 0.59 |
| Cr, mg/dl | 10.84 ± 2 | 10.66 ± 2.24 | 10.72 ± 2.3 | 10.07 ± 2.12 | 0.149 |
| UA, mg/dl | 7.56 ± 1.49 | 7.85 ± 1.35 | 7.65 ± 1.25 | 7.17 ± 1.93 | 0.622 |
| Ca, mg/dl | 13.32 ± 22.21 | 9.43 ± 0.39 | 9.26 ± 0.65 | 9.38 ± 0.79 | 0.225 |
| P, mg/dl | 4.65 ± 1.46 | 4.75 ± 1.35 | 4.41 ± 1.2 | 4.76 ± 1.4 | 0.55 |
| SBP, mmHg | 134.91 ± 22.34 | 138.85 ± 19.65 | 135.79 ± 15.02 | 140.88 ± 25.02 | 0.446 |
| DBP, mmHg | 78 ± 10.53 | 76.38 ± 10.38 | 76.15 ± 8.33 | 75.79 ± 9.69 | 0.479 |
Note: the abbreviations are the same as those denoted in Table 1. ∗p value of Spearman's association test using the raw data value of CD16+ monocytes and observed variables.